Sabra Health Care REIT Q2 2022 Earnings Report
Key Takeaways
Sabra Health Care REIT reported a net income of $0.07 per diluted common share, FFO of $0.36, Normalized FFO of $0.39, AFFO of $0.36, and Normalized AFFO of $0.38 for the second quarter of 2022. The company focused on strategic portfolio adjustments, including acquisitions and dispositions, and is working towards its long-term leverage target.
Net Income was $0.07 per diluted common share.
FFO was $0.36 per diluted common share.
Completed $264.9 million in investment activity with a weighted average initial cash yield of 6.9%.
Net Debt to Adjusted EBITDA ratio was 5.44x as of June 30, 2022, with plans to reduce it to around 5.0x by year-end.
Sabra Health Care REIT
Sabra Health Care REIT
Sabra Health Care REIT Revenue by Segment
Forward Guidance
The company anticipates dispositions, primarily of skilled nursing facilities, which will result in a more diversified portfolio. They are comfortable with temporarily elevated leverage and do not foresee needing to access capital markets for the rest of 2022. The company is pleased with its behavioral health expansion and the adaptive reuse of existing assets.
Positive Outlook
- Occupancy is increasing as the company moves from pandemic to endemic phase.
- Hiring has improved, and agency utilization is decreasing.
- Portfolio continues to be resilient with cash collections remaining in line.
- Anticipated dispositions will lead to a more diversified portfolio.
- Expansion in behavioral health through adaptive reuse of existing assets is creating value.
Challenges Ahead
- Occupancy is still hampered by labor shortages.
- Leverage is temporarily elevated.
- Agency utilization is still high.
- Skilled nursing facilities are being disposed.
- Labor shortages still exist.
Revenue & Expenses
Visualization of income flow from segment revenue to net income